Hydroxyurea Dose and Adherence Affect Hematologic Outcomes in Children With Sickle Cell Disease
Hydroxyurea Dose and Adherence Affect Hematologic Outcomes in Children With Sickle Cell Disease https://pediatricsnationwide.org/wp-content/uploads/2022/05/092821BS2731-1024x683.jpg 1024 683 JoAnna Pendergrass, DVM https://pediatricsnationwide.org/wp-content/uploads/2021/03/pendergrass_01.jpg
Optimal hydroxyurea dosing and medication adherence can improve hematologic outcomes for children with sickle cell anemia. For pediatric patients with sickle cell anemia, hydroxyurea is highly effective at reducing disease complications. However, it can be challenging for these patients to take hydroxyurea for the long term. “There are many barriers to medication adherence in…